vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
34.16
-2.66 (-7.24%)
Jun 26, 2026, 2:55 PM EDT - Market open

vTv Therapeutics Revenue

vTv Therapeutics had revenue of $36.84M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $36.84M, up 216,600.00% year-over-year.

Revenue (ttm)
$36.84M
Revenue Growth
+216,600.00%
P/S Ratio
12.48
Revenue / Employee
$1,416,885
Employees
26
Market Cap
423.85M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 20241.02M--
Dec 31, 2023---
Dec 31, 20222.02M-1.99M-49.61%
Dec 31, 20214.01M-2.41M-37.56%
Dec 31, 20206.41M3.65M132.05%
Dec 31, 20192.76M-9.67M-77.77%
Dec 31, 201812.43M12.14M4,172.85%
Dec 31, 2017291.00K-343.00K-54.10%
Dec 31, 2016634.00K115.00K22.16%
Dec 31, 2015519.00K-1.03M-66.49%
Dec 31, 20141.55M573.00K58.71%
Dec 31, 2013976.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE180.25M
Assembly Biosciences71.10M
Ovid Therapeutics7.12M
Ocugen4.47M
Shattuck Labs1.00M
Neurogene925.00K
Silence Therapeutics839.00K
Revenue Rankings

VTVT News

More News